Peru's President: We work tirelessly to ensure access to COVID-19 vaccines

Photo: ANDINA/Presidency of the Republic

Photo: ANDINA/Presidency of the Republic

00:30 | Lima, Feb. 18.

The President of the Republic Francisco Sagasti on Wednesday night affirmed that his administration does not rest, not even for a second, in the negotiation process for the procurement of vaccines against COVID-19, so that the necessary doses are guaranteed to the entire population.

In an interview with CNN en Español, the Head of State mentioned that the Executive Branch is currently focused on this task in such a way that those doses reach out to all Peruvian regions and benefit the population thanks to the efforts of health professionals in charge of immunizing citizens.

Asked about the doses that were used by officials outside clinical trials, the Peruvian leader indicated that his administration is characterized for not speculating or providing any hypotheses.

Regarding the negotiations carried out by his administration to procure vaccines, the President explained that the contract with the Sinopharm laboratory for the first one million doses —which are already being administered in Peru— was signed on January 6, 2021.

Moreover, Mr. Sagasti assured that none dose or figure will remain unjustified, as it will be known where they ended up.

"What we can do is guarantee the integrity of the clinical trials that have been conducted in Peru. What has happened is an aberration that should be treated as such and that should not affect (…) the well-earned prestige of Peru in the hosting of clinical trials," he concluded.


Published: 2/18/2021
Most read